Adrenergic and serotonergic receptor-blocking potencies of terazosin, a new antihypertensive agent, as assessed by radioligand binding assay.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D004285:Dogs; D066298:In Vitro Techniques; D008297:Male; D011224:Prazosin / Q000031:analogs & derivatives* / Q000494:pharmacology; D011869:Radioligand Assay; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D011941:Receptors, Adrenergic; D011985:Receptors, Serotonin; C041226:Terazosin; D011224:Prazosin